HLA-G and breast carcinoma: There is evidence that HLA-G-bearing EV are an especially crucial factor in immune-tolerance mechanisms operative in malignant diseases [21,22], as the total amount of soluble HLA-G has not been associated with disease progression and overall survival in breast cancer patients.